Concepedia

Danielle Porter

DP

Statistics

Publications

57

Citations

8.2K

H-Index

34

Active since

2012

Affiliations

Gilead Sciences (United States)(Current)

University of North Carolina at Chapel Hill

The University of Texas Medical Branch at Galveston

University of Alberta

Universität Hamburg

Danielle Porter is an author at Gilead Sciences (United States) specializing in medicine, virology, and viral pathogenesis.

ORCID

Top concepts

Publications per year

2012–2024

57

Publications

57

Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV

Timothy P. Sheahan, Amy Sims, Sarah R. Leist et al. · Nature Communications · 2020 · 1.8K citations · Full text

Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency

Calvin J. Gordon, Egor P. Tchesnokov, Emma Woolner et al. · Journal of Biological Chemistry · 2020 · 1K citations · Full text

The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus

Calvin J. Gordon, Egor P. Tchesnokov, Joy Y. Feng et al. · Journal of Biological Chemistry · 2020 · 878 citations · Full text

Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2

Brandi N. Williamson, Friederike Feldmann, Benjamin Schwarz et al. · Nature · 2020 · 732 citations · Full text

, , +7

Mechanism of Inhibition of Ebola Virus RNA-Dependent RNA Polymerase by Remdesivir

Egor P. Tchesnokov, Joy Y. Feng, Danielle Porter et al. · Viruses · 2019 · 641 citations · Full text

, , +16

1–5 of 57